Search research articles
Contact Us
Filters
Showing results (161-170 of 166) with videos related to
Page
of 17
Sort By:
You have reached the last page of results.
This site can display upto 166 results.
ESMO Open
|
April 9, 2022
Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors
S Ochsenreither, W M Fiedler, G D Conte, et al.
ESMO Open
|
July 16, 2022
Erratum to 'Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody Gatipotuzumab with the anti-EGFR Tomuzotuximab in patients with refractory solid tumors': [ESMO Open Volume 7, Issue 2, April 2022, 100447]
S Ochsenreither, W M Fiedler, G Del Conte, et al.
Plos One
|
September 13, 2019
A 32-channel parallel transmit system add-on for 7T MRI
Stephan Orzada, Klaus Solbach, Marcel Gratz, et al.
Annals of Surgery
|
June 16, 2023
Early-Onset Pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathology Features, and Oncological Outcomes
Alessandra Pulvirenti, Haley F Hauser, Laura M Fiedler, et al.
Urologie (Heidelberg, Germany)
|
March 14, 2022
[Safety and efficacy of en bloc vs. conventional transurethral resection of bladder tumors: a meta-analysis and systematic review]
D Oswald, P Pallauf, S Deininger, et al.
Circulation. Cardiovascular Genetics
|
June 10, 2010
Genetic regulation of serum phytosterol levels and risk of coronary artery disease
Daniel Teupser, Ronny Baber, Uta Ceglarek, et al.
Page
of 17
Search research articles
Search
Showing results (161-170 of 166) with videos related to
Sort By:
Page
of 17
You have reached the last page of results.
This site can display upto 166 results.
ESMO Open
|
April 9, 2022
Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab in patients with refractory solid tumors
S Ochsenreither, W M Fiedler, G D Conte, et al.
ESMO Open
|
July 16, 2022
Erratum to 'Safety and preliminary activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody Gatipotuzumab with the anti-EGFR Tomuzotuximab in patients with refractory solid tumors': [ESMO Open Volume 7, Issue 2, April 2022, 100447]
S Ochsenreither, W M Fiedler, G Del Conte, et al.
Plos One
|
September 13, 2019
A 32-channel parallel transmit system add-on for 7T MRI
Stephan Orzada, Klaus Solbach, Marcel Gratz, et al.
Annals of Surgery
|
June 16, 2023
Early-Onset Pancreatic Neuroendocrine Tumors: Clinical Presentation, Pathology Features, and Oncological Outcomes
Alessandra Pulvirenti, Haley F Hauser, Laura M Fiedler, et al.
Urologie (Heidelberg, Germany)
|
March 14, 2022
[Safety and efficacy of en bloc vs. conventional transurethral resection of bladder tumors: a meta-analysis and systematic review]
D Oswald, P Pallauf, S Deininger, et al.
Circulation. Cardiovascular Genetics
|
June 10, 2010
Genetic regulation of serum phytosterol levels and risk of coronary artery disease
Daniel Teupser, Ronny Baber, Uta Ceglarek, et al.
Page
of 17